BMPR2-Signalweg-Expression bei verschiedenen Patientengruppen mit pulmonal arterieller Hypertonie [BMPR2-pathway expression in distinct patient groups with pulmonary arterial hypertension]

The primary objective of the study is to determine the BMPR2 mRNA expression of PAH and CTEPH patients compared to healthy controls.

Study-ID: DRKS00030577

DZL Disease Area: PH

Study Type: Observational

DZL Role: DZL Investigator Initiated Trial

Funding: DZL

DZL Participating Sites: TLRC

Start Date: 01.10.2022

Completion Date: 31.10.2025

Status: Closed

DZL Investigator Initiated Trial

Disease: Pulmonary Hypertension (WHO Group 1 & Group 4)

DRKS-ID: DRKS00030577